Ameliorating TIMM50 Loss Slows Senescence by Improving Mitochondrial Structure and Function
Advanced Biology · 2025
DOI: 10.1002/adbi.202400597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, 2025. Verfasst von Amrita Nepalia und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental Biology and Genetics, Indian Institute of Science, Bengaluru, 560012, India. Hauptthemen laut MEDLINE: Cellular Senescence, Mitochondria, Mitochondrial Membrane Transport Proteins, Mitochondrial Proteins. Die Arbeit nennt 63 Literaturangaben.
Abstract (Originalsprache)
Mitochondrial dysfunction is an irrefutable hallmark of cellular senescence and aging. The dysfunction is marked by increased mitochondrial volume and reduced function, typified by low Adenosine Triphosphate (ATP) production and higher Reactive Oxygen Species (ROS) generation. Over the years, this dysfunction has been linked to Electron Transport Chain (ETC) malfunction and low NAD levels, augmented by poor mitophagy. However, the genetic regulation of mitochondrial dysfunction is still not clear. Here, using several senescence models, the first report on the role of the downregulation of a mitochondrial protein, Translocase of Inner Mitochondrial Membrane 50 (TIMM50), in senescence is presented. The downregulation of TIMM50 is also sufficient for triggering senescence through impaired mitochondrial function, characterized using a variety of mitochondrial function assessment assays. Reduced levels of TIMM50 initiated all the hallmarks of senescence, and overexpression significantly slowed senescence onset in response to an external trigger. The pathway analysis revealed that TIMM50 loss is mediated by the sirtuin1‐dependent downregulation of CCAAT enhancer binding protein alpha (CEBPα), a transcription activator for TIMM50 expression. To establish the translational value of the observation, screening several potential anti‐aging compounds revealed TIMM50 stabilizing and senescence‐delaying effects only for verapamil and mitochondrial ROS quencher, Mito (2‐(2,2,6,6‐Tetramethylpiperidin‐1‐oxyl‐4‐ylamino)‐2‐oxoethyl)triphenylphosphonium chloride (MitoTEMPO), both known anti‐aging entities. Overall, TIMM50 is identified as the key mitochondrial protein whose downregulation is a critical step in initiating cellular senescence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Developmental Biology and Genetics, Indian Institute of Science, Bengaluru, 560012, India.
- Longevity India Initiative, Indian Institute of Science, Bengaluru, 560012, India.
- Department of Bioengineering, Indian Institute of Science, Bengaluru, 560012, India.
ORCID-Profile: Amrita Nepalia, Deepak Kumar Saini
Zitieren
APA
Nepalia, A., & Saini, D. K. (2025). Ameliorating TIMM50 Loss Slows Senescence by Improving Mitochondrial Structure and Function. Advanced Biology. https://doi.org/10.1002/adbi.202400597
Vancouver
Nepalia A, Saini DK. Ameliorating TIMM50 Loss Slows Senescence by Improving Mitochondrial Structure and Function. Advanced Biology. 2025. doi:10.1002/adbi.202400597
BibTeX
@article{Nepalia2025,
author = {Nepalia, Amrita and Saini, Deepak Kumar},
title = {Ameliorating TIMM50 Loss Slows Senescence by Improving Mitochondrial Structure and Function},
journal = {Advanced Biology},
year = {2025},
doi = {10.1002/adbi.202400597}
}
EUVIMED